CVS results top estimates even as high medical costs drag down insurance unit

CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs. The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to$6 per share, which was in line with Wall Street's expectations. But CVS did not provide a revenue forecast for the year. It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain. Joyner succeede ...